SBS Australia reports that a dual therapy of antiviral drug and anti-cancer drugs was 100 percent successful in eliminating the hepatitis B virus (HBV) infections in pre-clinical animal trials. The combination treatment targets the cell signalling pathways that the hepatitis B virus uses to keep host liver cells alive.
Researcher Marc Pellegrini said "We are hopeful these promising results will be as successful in human clinical trials, which are currently underway in Melbourne, Perth and Adelaide,"
http://www.sbs.com.au/news/article/2015/04/21/new-treatment-promising-hep-b
(Score: 0) by Anonymous Coward on Tuesday April 21 2015, @10:08PM
Save your "Boo" for the politicians that decide to do bad things with technologies developed by scientists and engineers.